GT200000194A - Quimioterapia de combinacion. - Google Patents
Quimioterapia de combinacion.Info
- Publication number
- GT200000194A GT200000194A GT200000194A GT200000194A GT200000194A GT 200000194 A GT200000194 A GT 200000194A GT 200000194 A GT200000194 A GT 200000194A GT 200000194 A GT200000194 A GT 200000194A GT 200000194 A GT200000194 A GT 200000194A
- Authority
- GT
- Guatemala
- Prior art keywords
- agents
- combination
- carboplatin
- paclitaxel
- compartment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
LA INVENCION SE REFIERE A UN METODO PARA TRATAR TUMORES SOLIDOS AVANZADOS UTILIZANDO COMBINACIONES DE AGENTES ONCOLITICOS CONOCIDOS. EL USO DE LOS AGENTES JUNTOS PROPORCIONA INESPERADAMENTE UN EFICACIA MAYOR QUE SI SE EMPLEAN COMO AGENTES SIMPLES SOLAMENTE. HEMOS DESCUBIERTO UNA UNICA COMBINACION DE AGENTES ONCOLITICOS CONOCIDOS QUE EXHIBE UNA IMPORTANTE EFECTO SINERGETICO. LA COMBINACION UTILIZA EL AGENTE ACETILDINALINA, JUNTO CON PACLITAXEL Y/O CARBOPLATINA, EN UNA COMBINACION BINARIA O CON LOS TRES COMPONENTES SIMULTANEAMENTE. LA INVENCION COMPRENDE ADEMAS FORMULACIONES FARMACOLOGICAMENTE EFECTIVAS, TRATAMIENTOS, ADEMAS DE LA PRESENTACION EN UN COMPARTIMIENTO DE DOSIFICACION DE ACETIDINALINA Y EN OTRO COMPARTIMIENTO UNA DOSIFICACION DE CARBOPLATINA Y/O OTRO COMPARTIMIENTO DE DOSIFICACION DE PACLITAXEL. UNA COMBINACION DE AGENTES ANTINEOPLASICOS QUE COMPRENDEN UNA CANTIDAD ANTITUMOR DE ACETIDINALINA Y UNA CANTIDAD ANTITUMOR DE PACLITAXEL Y / O CARBOPLATINA. LA ACETILDINALINA EN COMBINACION CON PACLITAXEL Y / O CARBOPLATINA ES SINERGISTICA PARA TRATAR EL CANCER.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16488999P | 1999-11-10 | 1999-11-10 | |
| US22256100P | 2000-08-03 | 2000-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200000194A true GT200000194A (es) | 2002-05-03 |
Family
ID=26860956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200000194A GT200000194A (es) | 1999-11-10 | 2000-11-09 | Quimioterapia de combinacion. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1229916A2 (es) |
| JP (1) | JP2003513912A (es) |
| KR (1) | KR20020060226A (es) |
| CN (1) | CN1387438A (es) |
| AR (1) | AR026400A1 (es) |
| AU (1) | AU1583201A (es) |
| CA (1) | CA2386876A1 (es) |
| GT (1) | GT200000194A (es) |
| HU (1) | HUP0203153A3 (es) |
| IL (1) | IL149363A0 (es) |
| NZ (1) | NZ518668A (es) |
| PA (1) | PA8506201A1 (es) |
| PE (1) | PE20011028A1 (es) |
| PL (1) | PL355170A1 (es) |
| SV (1) | SV2001000212A (es) |
| UY (1) | UY26431A1 (es) |
| WO (1) | WO2001034131A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20022216A3 (cs) * | 2001-07-02 | 2003-05-14 | Warner-Lambert Company | Kombinační chemoterapie |
| PE20050206A1 (es) * | 2003-05-26 | 2005-03-26 | Schering Ag | Composicion farmaceutica que contiene un inhibidor de histona deacetilasa |
| HUE028490T2 (en) | 2003-12-02 | 2016-12-28 | Univ Ohio State Res Found | Short-chain fatty acids fixed to the Zn2-chelating motif as a new class of histone deacetylase inhibitors |
| US7951780B2 (en) * | 2004-02-25 | 2011-05-31 | Astellas Pharma Inc. | Antitumor agent |
| AU2005264063B2 (en) * | 2004-07-16 | 2009-09-10 | Pfizer Products Inc. | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody |
| EP2415382B1 (en) | 2010-08-06 | 2012-08-29 | Electrolux Home Products Corporation N.V. | Table top dishwasher |
| EP3461480A1 (en) | 2017-09-27 | 2019-04-03 | Onxeo | Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer |
| EP3461488A1 (en) | 2017-09-27 | 2019-04-03 | Onxeo | Combination of a dbait molecule and a hdac inhibitor for treating cancer |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2023041805A1 (en) | 2021-09-20 | 2023-03-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor |
| WO2023194441A1 (en) | 2022-04-05 | 2023-10-12 | Istituto Nazionale Tumori Irccs - Fondazione G. Pascale | Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219974A (en) * | 1986-04-22 | 1989-08-29 | Goedecke Ag | N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases |
-
2000
- 2000-11-03 WO PCT/US2000/030377 patent/WO2001034131A2/en not_active Application Discontinuation
- 2000-11-03 HU HU0203153A patent/HUP0203153A3/hu unknown
- 2000-11-03 AU AU15832/01A patent/AU1583201A/en not_active Abandoned
- 2000-11-03 CA CA002386876A patent/CA2386876A1/en not_active Abandoned
- 2000-11-03 EP EP00978360A patent/EP1229916A2/en not_active Withdrawn
- 2000-11-03 IL IL14936300A patent/IL149363A0/xx unknown
- 2000-11-03 JP JP2001536131A patent/JP2003513912A/ja active Pending
- 2000-11-03 CN CN00815470A patent/CN1387438A/zh active Pending
- 2000-11-03 KR KR1020027005970A patent/KR20020060226A/ko not_active Application Discontinuation
- 2000-11-03 PL PL00355170A patent/PL355170A1/xx not_active Application Discontinuation
- 2000-11-03 NZ NZ518668A patent/NZ518668A/en unknown
- 2000-11-07 SV SV2000000212A patent/SV2001000212A/es not_active Application Discontinuation
- 2000-11-09 UY UY26431A patent/UY26431A1/es not_active Application Discontinuation
- 2000-11-09 GT GT200000194A patent/GT200000194A/es unknown
- 2000-11-09 PE PE2000001196A patent/PE20011028A1/es not_active Application Discontinuation
- 2000-11-09 PA PA20008506201A patent/PA8506201A1/es unknown
- 2000-11-09 AR ARP000105899A patent/AR026400A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL149363A0 (en) | 2002-11-10 |
| HUP0203153A2 (hu) | 2003-01-28 |
| AR026400A1 (es) | 2003-02-12 |
| WO2001034131A3 (en) | 2002-05-10 |
| KR20020060226A (ko) | 2002-07-16 |
| AU1583201A (en) | 2001-06-06 |
| JP2003513912A (ja) | 2003-04-15 |
| UY26431A1 (es) | 2000-12-29 |
| NZ518668A (en) | 2004-04-30 |
| EP1229916A2 (en) | 2002-08-14 |
| CA2386876A1 (en) | 2001-05-17 |
| PL355170A1 (en) | 2004-04-05 |
| CN1387438A (zh) | 2002-12-25 |
| PA8506201A1 (es) | 2002-12-11 |
| HUP0203153A3 (en) | 2005-01-28 |
| PE20011028A1 (es) | 2001-10-12 |
| WO2001034131A2 (en) | 2001-05-17 |
| SV2001000212A (es) | 2001-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28213A1 (es) | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. | |
| UY27943A1 (es) | Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos | |
| CL2008002224A1 (es) | Composicion farmaceutica que comprende a) un compuesto seleccionado entre paclitaxel, docetaxel, ispinesib, tiazoloquinolina, entre otro, y b) compuestos inhibidores de aurora quinasa seleccionados entre derivados de imidazopirazina; uso de combinacion y de la composicion para tratar el cancer. | |
| CR8181A (es) | Uso de una combinacion de un inhibidor de la cinasa del receptor del factor de crecimiento epidermico y agentes citotoxicos para el tratamiento e inhibicion del cancer | |
| DOP2012000290A (es) | 4-yodo-3-nitrobenzamida en combinacion con agentes anti-tumorales para el uso en el tratamiento de cancer utero y cancer de ovario | |
| AR048502A1 (es) | Sinergia terapeutica de compuestos anti-cancer | |
| ATE538103T1 (de) | Chinazolinonverbindungen als antikrebsmittel | |
| BRPI0506977A (pt) | composto de tetrahidrocarbolina como agentes anticáncer | |
| UY28287A1 (es) | Combinaciones para el tratamiento de enfermedades que impican proliferación, migración o apoptosis celulares de células de mieloma, o angiogénesis | |
| AR054094A1 (es) | Tratamientos de cancer | |
| BRPI0612845A8 (pt) | composto, formulação farmacêutica, métodos para tratar câncer e para sintetizar um composto de fórmula alq-dispasador | |
| WO2004030627A3 (en) | Synergistic methods and compositions for treating cancer | |
| AR056801A1 (es) | Terapia combinada anti- proliferativa con determinados agentes quimioterapeuticos basados en platino e inhibidores de egfr o analogos de pirimidina | |
| CR7899A (es) | Compuestos de triciclicos inhbidores de proteina quinasa para mejorar la eficacia de agentes antienoplasticos y derivados de diazenpamdionilo como inhibidores de quinasa | |
| AR052774A1 (es) | Inmunoterapia para trastornos autoinmunes | |
| EP1622608A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANCER | |
| BRPI0607809A2 (pt) | uso de uma composição compreendendo nanopartìculas, composição e kit | |
| BRPI0207961B8 (pt) | uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
| CO6300964A2 (es) | Una composicion farmaceutica que comprende una combinacion de un agente quimioterapeutico y un anticuerpo 3 antiglipicano | |
| AR023616A1 (es) | Preparaciones combinadas que comprenden derivados de antraciclina | |
| GT200000194A (es) | Quimioterapia de combinacion. | |
| BRPI0511475A (pt) | combinação, composição farmacêutica, uso de uma combinação, e, método para o tratamento de cáncer | |
| AR040792A1 (es) | Combinaciones terapeuticas de inhibidores de quinasa de erb b y terapias antineoplasicas | |
| ATE509630T1 (de) | Pankreaskrebsbehandlung mit na+/k+-atpase-hemmern | |
| EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY |